Pleuroparenchymal fibroelastosis: A pattern of chronic lung injury

Jason N. Rosenbaum, Yasmeen M. Butt, Karen A. Johnson, Keith Meyer, Kiran Batra, Jeffrey P. Kanne, José R. Torrealba

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Pleuroparenchymal fibroelastosis (PPFE) is a rare condition currently described as an upper lobe subpleural and interstitial proliferation of predominantly elastic fibers. The etiology is unknown, and no specific diagnostic criteria have been reported. Here we report 5 cases of PPFE, 1 man and 4 women, 3 of them diagnosed at the time autopsy, 1 diagnosed in an explanted lung, and 1 diagnosed on a surgical wedge biopsy. The average age of diagnosis among this series is 73 years, and the duration of pulmonary symptoms ranged from 14 months to at least 9 years. Two patients had been exposed to specific medications (daptomycin and dapsone) preceding the development of pulmonary symptoms, and 1 patient developed eosinophilic pneumonia in the course of the disease. Four patients had clinical evidence of fibrous interstitial pneumonia. We found evidence of diffuse parenchymal fibroelastosis involving both upper and lower lobes in all 5 cases, suggesting that the disease may be a more diffuse condition than previously reported. PPFE may actually represent a pattern of chronic lung injury rather than a specific entity and may be seen in association with a variety of clinicoradiologic conditions. Based on our findings in this series and the most recent publications of the subject, we propose the following set of diagnostic criteria for PPFE: multilobar subpleural and/or centrilobular fibrous interstitial pneumonia characterized by an extensive (>80%) proliferation of elastic fibers in nonatelectatic lung, along with absent to mild chronic inflammation, and absent to rare granulomas.

Original languageEnglish (US)
Pages (from-to)137-146
Number of pages10
JournalHuman Pathology
Volume46
Issue number1
DOIs
StatePublished - Jan 1 2015

Fingerprint

Lung Injury
Lung
Elastic Tissue
Interstitial Lung Diseases
Daptomycin
Pulmonary Eosinophilia
Dapsone
Granuloma
Autopsy
Inflammation
Biopsy

Keywords

  • Dapsone Usual interstitial pneumonia
  • Daptomycin
  • Interstitial fibrosis
  • Pleuroparenchymal fibroelastosis
  • PPFE
  • UIP

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Medicine(all)

Cite this

Pleuroparenchymal fibroelastosis : A pattern of chronic lung injury. / Rosenbaum, Jason N.; Butt, Yasmeen M.; Johnson, Karen A.; Meyer, Keith; Batra, Kiran; Kanne, Jeffrey P.; Torrealba, José R.

In: Human Pathology, Vol. 46, No. 1, 01.01.2015, p. 137-146.

Research output: Contribution to journalArticle

Rosenbaum JN, Butt YM, Johnson KA, Meyer K, Batra K, Kanne JP et al. Pleuroparenchymal fibroelastosis: A pattern of chronic lung injury. Human Pathology. 2015 Jan 1;46(1):137-146. https://doi.org/10.1016/j.humpath.2014.10.007
Rosenbaum, Jason N. ; Butt, Yasmeen M. ; Johnson, Karen A. ; Meyer, Keith ; Batra, Kiran ; Kanne, Jeffrey P. ; Torrealba, José R. / Pleuroparenchymal fibroelastosis : A pattern of chronic lung injury. In: Human Pathology. 2015 ; Vol. 46, No. 1. pp. 137-146.
@article{0a6853e3c9dd424bae03c6614c8d77dc,
title = "Pleuroparenchymal fibroelastosis: A pattern of chronic lung injury",
abstract = "Pleuroparenchymal fibroelastosis (PPFE) is a rare condition currently described as an upper lobe subpleural and interstitial proliferation of predominantly elastic fibers. The etiology is unknown, and no specific diagnostic criteria have been reported. Here we report 5 cases of PPFE, 1 man and 4 women, 3 of them diagnosed at the time autopsy, 1 diagnosed in an explanted lung, and 1 diagnosed on a surgical wedge biopsy. The average age of diagnosis among this series is 73 years, and the duration of pulmonary symptoms ranged from 14 months to at least 9 years. Two patients had been exposed to specific medications (daptomycin and dapsone) preceding the development of pulmonary symptoms, and 1 patient developed eosinophilic pneumonia in the course of the disease. Four patients had clinical evidence of fibrous interstitial pneumonia. We found evidence of diffuse parenchymal fibroelastosis involving both upper and lower lobes in all 5 cases, suggesting that the disease may be a more diffuse condition than previously reported. PPFE may actually represent a pattern of chronic lung injury rather than a specific entity and may be seen in association with a variety of clinicoradiologic conditions. Based on our findings in this series and the most recent publications of the subject, we propose the following set of diagnostic criteria for PPFE: multilobar subpleural and/or centrilobular fibrous interstitial pneumonia characterized by an extensive (>80{\%}) proliferation of elastic fibers in nonatelectatic lung, along with absent to mild chronic inflammation, and absent to rare granulomas.",
keywords = "Dapsone Usual interstitial pneumonia, Daptomycin, Interstitial fibrosis, Pleuroparenchymal fibroelastosis, PPFE, UIP",
author = "Rosenbaum, {Jason N.} and Butt, {Yasmeen M.} and Johnson, {Karen A.} and Keith Meyer and Kiran Batra and Kanne, {Jeffrey P.} and Torrealba, {Jos{\'e} R.}",
year = "2015",
month = "1",
day = "1",
doi = "10.1016/j.humpath.2014.10.007",
language = "English (US)",
volume = "46",
pages = "137--146",
journal = "Human Pathology",
issn = "0046-8177",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Pleuroparenchymal fibroelastosis

T2 - A pattern of chronic lung injury

AU - Rosenbaum, Jason N.

AU - Butt, Yasmeen M.

AU - Johnson, Karen A.

AU - Meyer, Keith

AU - Batra, Kiran

AU - Kanne, Jeffrey P.

AU - Torrealba, José R.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Pleuroparenchymal fibroelastosis (PPFE) is a rare condition currently described as an upper lobe subpleural and interstitial proliferation of predominantly elastic fibers. The etiology is unknown, and no specific diagnostic criteria have been reported. Here we report 5 cases of PPFE, 1 man and 4 women, 3 of them diagnosed at the time autopsy, 1 diagnosed in an explanted lung, and 1 diagnosed on a surgical wedge biopsy. The average age of diagnosis among this series is 73 years, and the duration of pulmonary symptoms ranged from 14 months to at least 9 years. Two patients had been exposed to specific medications (daptomycin and dapsone) preceding the development of pulmonary symptoms, and 1 patient developed eosinophilic pneumonia in the course of the disease. Four patients had clinical evidence of fibrous interstitial pneumonia. We found evidence of diffuse parenchymal fibroelastosis involving both upper and lower lobes in all 5 cases, suggesting that the disease may be a more diffuse condition than previously reported. PPFE may actually represent a pattern of chronic lung injury rather than a specific entity and may be seen in association with a variety of clinicoradiologic conditions. Based on our findings in this series and the most recent publications of the subject, we propose the following set of diagnostic criteria for PPFE: multilobar subpleural and/or centrilobular fibrous interstitial pneumonia characterized by an extensive (>80%) proliferation of elastic fibers in nonatelectatic lung, along with absent to mild chronic inflammation, and absent to rare granulomas.

AB - Pleuroparenchymal fibroelastosis (PPFE) is a rare condition currently described as an upper lobe subpleural and interstitial proliferation of predominantly elastic fibers. The etiology is unknown, and no specific diagnostic criteria have been reported. Here we report 5 cases of PPFE, 1 man and 4 women, 3 of them diagnosed at the time autopsy, 1 diagnosed in an explanted lung, and 1 diagnosed on a surgical wedge biopsy. The average age of diagnosis among this series is 73 years, and the duration of pulmonary symptoms ranged from 14 months to at least 9 years. Two patients had been exposed to specific medications (daptomycin and dapsone) preceding the development of pulmonary symptoms, and 1 patient developed eosinophilic pneumonia in the course of the disease. Four patients had clinical evidence of fibrous interstitial pneumonia. We found evidence of diffuse parenchymal fibroelastosis involving both upper and lower lobes in all 5 cases, suggesting that the disease may be a more diffuse condition than previously reported. PPFE may actually represent a pattern of chronic lung injury rather than a specific entity and may be seen in association with a variety of clinicoradiologic conditions. Based on our findings in this series and the most recent publications of the subject, we propose the following set of diagnostic criteria for PPFE: multilobar subpleural and/or centrilobular fibrous interstitial pneumonia characterized by an extensive (>80%) proliferation of elastic fibers in nonatelectatic lung, along with absent to mild chronic inflammation, and absent to rare granulomas.

KW - Dapsone Usual interstitial pneumonia

KW - Daptomycin

KW - Interstitial fibrosis

KW - Pleuroparenchymal fibroelastosis

KW - PPFE

KW - UIP

UR - http://www.scopus.com/inward/record.url?scp=84915791119&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84915791119&partnerID=8YFLogxK

U2 - 10.1016/j.humpath.2014.10.007

DO - 10.1016/j.humpath.2014.10.007

M3 - Article

C2 - 25454481

AN - SCOPUS:84915791119

VL - 46

SP - 137

EP - 146

JO - Human Pathology

JF - Human Pathology

SN - 0046-8177

IS - 1

ER -